Since bottoming out in April 2025, Relay Therapeutics (RLAY) shares have skyrocketed by as much as 1,074%. Now the biotech firm has a fresh breakout in its sights. With its 10-week moving average continuing its long ascent, the Cambridge, Mass.-based company earns a coveted blue dot in MarketSurge, a clear indication of stock market leadership.
Biotech Taps AI And Machine…
Extract — continue reading at the source.
Related stories
CoreWeave CEO Michael Intrator Sold Over 13,000 Shares for $1.2 Million. What Does This Mean for Investors?
Warren Buffett's Hand-Picked Successor, Greg Abel, Has 72% of Berkshire Hathaway's Portfolio Invested in Just 5 Stocks. Here's My Top Pick for August.
Tariffs just pushed Hyundai deeper into America
Insider Liquidates More Than 26,000 Shares of Fintech Stock for Tax Obligations
Which Consumer Staples ETF Is a Better Buy: Invesco's RSPS or SPDR's XLP?
Citi Predicts Up to 410% Rally for These 2 ‘Strong Buy’ Stocks